Vimarsana
Biggest News Aggregation in the World

Robertj Gould News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robertj Gould. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robertj Gould Today - Breaking & Trending Today

Appeals court upholds conviction of man sentenced to 126 years in prison for sexually assaulting 2 children in McHenry County - Vimarsana News

Appeals court upholds conviction of man sentenced to 126 years in prison for sexually assaulting 2 children in McHenry County

An appeals court has upheld a former McHenry County man's conviction after he was sentenced to 126 years in prison for sexually assaulting two children over a thousand times over the span of 14 years.

Advocacy and Industry Partners Launch New Global Coalition to Speed Delivery of New Therapies for Facioscapulohumeral Muscular Dystrophy (FSHD) - Vimarsana News

Advocacy and Industry Partners Launch New Global Coalition to Speed Delivery of New Therapies for Facioscapulohumeral Muscular Dystrophy (FSHD)

Project Mercury unites patients, industry, research and clinical communities in groundbreaking initiativeRANDOLPH, Mass. and CAMBRIDGE, Mass., June 20, 2023 -- Today on World FSHD Day, the FSHD... | June 20, 2023

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2023 Earnings Call Transcript - Vimarsana News

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Fulcrum Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode.

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023 - Vimarsana News

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023

― Appointed Alex C. Sapir CEO & President, effective July 1st, 2023 ― ― On track to complete enrollment in Phase 3 REACH trial of losmapimod in facioscapulohumeral... | May 15, 2023

Fulcrum Therapeutics tabs Alex Sapir as CEO - Vimarsana News

Fulcrum Therapeutics tabs Alex Sapir as CEO

Following the transaction, the new company will be responsible for developing and commercializing zagociguat and CY3018.